Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TGTX | SYRE | RGEN | ||
| Company | Tg Therapeutics | Spyre Therapeutics Inc | Repligen Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 43.23 | 77.00 | 116.29 | ||
| High | 44.00 | 77.20 | 119.01 | ||
| Low | 42.28 | 73.22 | 113.26 | ||
| Latest | 42.54 | 75.04 | 113.60 | ||
| Change | -0.60 | -1.39 | -2.31 | ||
| % Change | -1.39% | -1.82% | -1.99% | ||
| Volume | 2,382,900 | 1,760,500 | 1,462,600 | ||
| 20-Day Average Volume | 2,422,355 | 1,390,870 | 1,182,835 | ||
| Previous Close | 43.14 | 76.43 | 115.91 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 37.29 | 71.87 | 122.21 | ||
| 20-Day Raw Stochastic | 81.52% | 73.52% | 12.83% | ||
| 20-Day Relative Strength | 69.91 | 66.74 | 42.46 | ||
| Weighted Alpha | +34.45 | +350.34 | -17.53 | ||
| Today's Opinion | 88% Buy | 100% Buy | 88% Sell | ||
| Previous Opinion | 88% Buy | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 40% Buy | 100% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.84% since 05/05/26 | +5.68% since 05/05/26 | -9.56% since 05/05/26 | ||
| Low | 36.25 on 05/06/26 | 70.11 on 05/06/26 | 113.26 on 05/12/26 | ||
| High | 44.65 on 05/08/26 | 78.80 on 05/11/26 | 131.53 on 05/06/26 | ||
| 1-Month | |||||
| %Chg | +26.12% since 04/10/26 | +46.31% since 04/10/26 | -5.41% since 04/10/26 | ||
| Low | 33.23 on 05/01/26 | 59.02 on 04/13/26 | 109.50 on 04/23/26 | ||
| High | 44.65 on 05/08/26 | 78.80 on 05/11/26 | 141.46 on 04/21/26 | ||
| 3-Month | |||||
| %Chg | +49.68% since 02/12/26 | +115.38% since 02/12/26 | -14.35% since 02/12/26 | ||
| Low | 26.76 on 03/12/26 | 34.96 on 02/17/26 | 109.50 on 04/23/26 | ||
| High | 44.65 on 05/08/26 | 78.80 on 05/11/26 | 141.46 on 04/21/26 | ||
| 6-Month | |||||
| %Chg | +37.18% since 11/12/25 | +220.27% since 11/12/25 | -28.11% since 11/12/25 | ||
| Low | 26.76 on 03/12/26 | 22.13 on 11/14/25 | 109.50 on 04/23/26 | ||
| High | 44.65 on 05/08/26 | 78.80 on 05/11/26 | 175.77 on 01/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,604,043 | 6,637,258 | 6,538,252 | ||
| Shares Outstanding, K | 153,084 | 86,841 | 56,408 | ||
| Annual Sales | 616,290,000 | 0 | 738,260,000 | ||
| Annual Net Income | 447,180,000 | -155,200,000 | 48,890,000 | ||
| Last Quarter Sales | 204,920,000 | 0 | 194,260,000 | ||
| Last Quarter Net Income | 19,780,000 | -69,010,000 | 8,330,000 | ||
| 60-Month Beta | 1.68 | 3.12 | 1.09 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.17 on 05/06/26 | -0.74 on 05/05/26 | 0.48 on 05/05/26 | ||
| Earnings Date | 08/03/26 | 08/04/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 14.73 | 0.00 | 68.59 | ||